Modulatory effect of amifostine (WR-1065) against genotoxicity and oxidative stress induced by methotrexate in human umbilical vein endothelial cells (HUVECs)
Authors:
- 3 August 2023
- journal article
- research article
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 33 (9) , 755-765
Abstract
Amifostine is used in chemotherapy and radiotherapy as a cytoprotective adjuvant alongside DNA-binding chemotherapeutic agents. It functions by reducing free radicals and detoxifying harmful metabolites. Methotrexate, as an antimetabolite drug has been considered for treating various cancers and autoimmune diseases. However, the cytotoxic effects of methotrexate extend beyond tumor cells to crucial organs, including the heart. This study applied the HUVEC cell line as a reference in vitro model for researching the characteristics of vascular endothelium and cardiotoxicity. The current study aimed to assess amifostine's potential cytoprotective properties against methotrexate-induced cellular damage. Cytotoxicity was measured using the MTT assay. Apoptotic rates were evaluated by Annexin V-FITC/PI staining via flow cytometry. The genoprotective effect of amifostine was determined using the comet assay. Cells were exposed to various amifostine doses (10-200 μg/mL) and methotrexate (2.5 μM) in pretreatment culture condition. Methotrexate at 2.5 μM revealed cytotoxicity, apoptosis, oxidative stress and genotoxicity while highlighting amifostine's cyto/geno protective properties on HUVECs. Amifostine significantly decreased the levels of ROS and LPO while preserving the status of GSH and SOD activity. Furthermore, it inhibited genotoxicity (tail length, %DNA in tail, and tail moment) in the comet assay. Amifostine markedly attenuated methotrexate-induced apoptotic cell death (early and late apoptotic rates). These findings convey that amifostine can operate as a cytoprotectant agent.Keywords
This publication has 55 references indexed in Scilit:
- RETRACTED ARTICLE: The cardioprotective effects of L-carnitine on rat cardiac injury, apoptosis, and oxidative stress caused by amethopterinEnvironmental Science and Pollution Research, 2016
- Two New Faces of Amifostine: Protector from DNA Damage in Normal Cells and Inhibitor of DNA Repair in Cancer CellsJournal of Medicinal Chemistry, 2016
- Review of therapeutic drug monitoring of anticancer drugs part 1 – CytotoxicsEuropean Journal of Cancer, 2014
- The comet assay: topical issuesMutagenesis, 2008
- Extremely Low Doses of X-Radiation can Induce Adaptive Responses in Mouse ProstateDose-Response, 2007
- Acute Cardiac Toxicity Associated with High‐Dose Intravenous Methotrexate Therapy: Case Report and Review of the LiteraturePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcomaCancer, 2004
- Amifostine has antiangiogenic propertiesin vitroby changing the redox status of human endothelial cellsFree Radical Research, 2003
- Genotoxicity of idarubicin and its modulation by vitamins C and E and amifostineChemico-Biological Interactions, 2002
- Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cellsBiochemical Pharmacology, 2002